463 related articles for article (PubMed ID: 30465765)
1. Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons.
Engle SJ; Blaha L; Kleiman RJ
Neuron; 2018 Nov; 100(4):783-797. PubMed ID: 30465765
[TBL] [Abstract][Full Text] [Related]
2. Research on neurodegenerative diseases using induced pluripotent stem cells.
Imamura K; Inoue H
Psychogeriatrics; 2012 Jun; 12(2):115-9. PubMed ID: 22712645
[TBL] [Abstract][Full Text] [Related]
3. Modeling neurodegenerative diseases using stem cells: is it accelerating drug discovery?
Ebert AD
Future Med Chem; 2012 Sep; 4(13):1651-3. PubMed ID: 22924501
[No Abstract] [Full Text] [Related]
4. Molecular Profiling of Human Induced Pluripotent Stem Cell-Derived Cells and their Application for Drug Safety Study.
Matsui T; Miyamoto N; Saito F; Shinozawa T
Curr Pharm Biotechnol; 2020; 21(9):807-828. PubMed ID: 32321398
[TBL] [Abstract][Full Text] [Related]
5. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
6. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
[TBL] [Abstract][Full Text] [Related]
7. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
Corti S; Faravelli I; Cardano M; Conti L
Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
[TBL] [Abstract][Full Text] [Related]
8. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
[TBL] [Abstract][Full Text] [Related]
9. Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids.
Shcheglovitov A; Peterson RT
Neurotherapeutics; 2021 Jul; 18(3):1478-1489. PubMed ID: 34595731
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cell derived cardiac models: effects of Thymosin β4.
Ziegler T; Hinkel R; Kupatt C
Expert Opin Biol Ther; 2018 Jul; 18(sup1):111-120. PubMed ID: 30063852
[TBL] [Abstract][Full Text] [Related]
11. The use of induced pluripotent stem cells in drug development.
Inoue H; Yamanaka S
Clin Pharmacol Ther; 2011 May; 89(5):655-61. PubMed ID: 21430656
[TBL] [Abstract][Full Text] [Related]
12. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
Qian L; Tcw J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
[TBL] [Abstract][Full Text] [Related]
13. Human iPSC-derived miniature organs: a tool for drug studies.
Takebe T; Taniguchi H
Clin Pharmacol Ther; 2014 Sep; 96(3):310-3. PubMed ID: 24848506
[TBL] [Abstract][Full Text] [Related]
14. Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.
Tzatzalos E; Abilez OJ; Shukla P; Wu JC
Adv Drug Deliv Rev; 2016 Jan; 96():234-244. PubMed ID: 26428619
[TBL] [Abstract][Full Text] [Related]
15. An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells.
Canfield SG; Stebbins MJ; Morales BS; Asai SW; Vatine GD; Svendsen CN; Palecek SP; Shusta EV
J Neurochem; 2017 Mar; 140(6):874-888. PubMed ID: 27935037
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review.
Saito-Diaz K; Zeltner N
Clin Auton Res; 2019 Aug; 29(4):367-384. PubMed ID: 30631982
[TBL] [Abstract][Full Text] [Related]
17. Long-term electrophysiological activity and pharmacological response of a human induced pluripotent stem cell-derived neuron and astrocyte co-culture.
Odawara A; Saitoh Y; Alhebshi AH; Gotoh M; Suzuki I
Biochem Biophys Res Commun; 2014 Jan; 443(4):1176-81. PubMed ID: 24406164
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing.
Sinnecker D; Laugwitz KL; Moretti A
Pharmacol Ther; 2014 Aug; 143(2):246-52. PubMed ID: 24657289
[TBL] [Abstract][Full Text] [Related]
19. Human Induced Pluripotent Stem Cell Derived Neuronal Cells Cultured on Chemically-Defined Hydrogels for Sensitive In Vitro Detection of Botulinum Neurotoxin.
Pellett S; Schwartz MP; Tepp WH; Josephson R; Scherf JM; Pier CL; Thomson JA; Murphy WL; Johnson EA
Sci Rep; 2015 Sep; 5():14566. PubMed ID: 26411797
[TBL] [Abstract][Full Text] [Related]
20. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
